A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer

BACKGROUND: The aim of this study was to evaluate the efficacy and safety of nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer (NSCLC). METHODS: Chemotherapy-naïve patients with advanced NSCLC were eligible. In the phase I dose-escalation cohort (3...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattori, Yoshihiro, Kono, Yuko, Itoh, Shoichi, Inoue, Takako, Urata, Yoshiko, Kawa, Yoshitaka, Tohnai, Rie, Kumagai, Toru, Nishino, Kazumi, Uozumi, Ryuji, Morita, Satoshi, Negoro, Shunichi, Imamura, Fumio, Satouchi, Miyako
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014598/
https://www.ncbi.nlm.nih.gov/pubmed/32046667
http://dx.doi.org/10.1186/s12885-020-6588-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014598/
https://www.ncbi.nlm.nih.gov/pubmed/32046667
http://dx.doi.org/10.1186/s12885-020-6588-y

Ejemplares similares